263 related articles for article (PubMed ID: 18332212)
1. A novel Treponema pallidum antigen, TP0136, is an outer membrane protein that binds human fibronectin.
Brinkman MB; McGill MA; Pettersson J; Rogers A; Matejková P; Smajs D; Weinstock GM; Norris SJ; Palzkill T
Infect Immun; 2008 May; 76(5):1848-57. PubMed ID: 18332212
[TBL] [Abstract][Full Text] [Related]
2. Treponema pallidum subsp. pallidum TP0136 protein is heterogeneous among isolates and binds cellular and plasma fibronectin via its NH2-terminal end.
Ke W; Molini BJ; Lukehart SA; Giacani L
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003662. PubMed ID: 25793702
[TBL] [Abstract][Full Text] [Related]
3. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
Parveen N; Fernandez MC; Haynes AM; Zhang RL; Godornes BC; Centurion-Lara A; Giacani L
Vaccine; 2019 Mar; 37(13):1807-1818. PubMed ID: 30797635
[TBL] [Abstract][Full Text] [Related]
4. Effect of anti-TP0136 antibodies on the progression of lesions in an infected rabbit model.
Li QL; Tong ML; Liu LL; Lin LR; Lin Y; Yang TC
Int Immunopharmacol; 2020 Jun; 83():106428. PubMed ID: 32217461
[TBL] [Abstract][Full Text] [Related]
5. Analysis of host cell binding specificity mediated by the Tp0136 adhesin of the syphilis agent Treponema pallidum subsp. pallidum.
Djokic V; Giacani L; Parveen N
PLoS Negl Trop Dis; 2019 May; 13(5):e0007401. PubMed ID: 31071095
[TBL] [Abstract][Full Text] [Related]
6. Two Potential Syphilis Vaccine Candidates Inhibit Dissemination of
Xu M; Xie Y; Zheng K; Luo H; Tan M; Zhao F; Zeng T; Wu Y
Front Immunol; 2021; 12():759474. PubMed ID: 34899710
[TBL] [Abstract][Full Text] [Related]
7. Immunological evaluation and cellular location analysis of the TprI antigen of Treponema pallidum subsp. pallidum.
Giacani L; Sambri V; Marangoni A; Cavrini F; Storni E; Donati M; Corona S; Lanzarini P; Cevenini R
Infect Immun; 2005 Jun; 73(6):3817-22. PubMed ID: 15908421
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional and immunological analysis of the putative outer membrane protein and vaccine candidate TprL of Treponema pallidum.
Haynes AM; Fernandez M; Romeis E; Mitjà O; Konda KA; Vargas SK; Eguiluz M; Caceres CF; Klausner JD; Giacani L
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008812. PubMed ID: 33497377
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses elicited against the Treponema pallidum repeat proteins differ during infection with different isolates of Treponema pallidum subsp. pallidum.
Leader BT; Hevner K; Molini BJ; Barrett LK; Van Voorhis WC; Lukehart SA
Infect Immun; 2003 Oct; 71(10):6054-7. PubMed ID: 14500529
[TBL] [Abstract][Full Text] [Related]
10. Polypeptides of Treponema pallidum: progress toward understanding their structural, functional, and immunologic roles. Treponema Pallidum Polypeptide Research Group.
Norris SJ
Microbiol Rev; 1993 Sep; 57(3):750-79. PubMed ID: 8246847
[TBL] [Abstract][Full Text] [Related]
11. Subfamily I Treponema pallidum repeat protein family: sequence variation and immunity.
Sun ES; Molini BJ; Barrett LK; Centurion-Lara A; Lukehart SA; Van Voorhis WC
Microbes Infect; 2004 Jul; 6(8):725-37. PubMed ID: 15207819
[TBL] [Abstract][Full Text] [Related]
12. Sequence Variation of Rare Outer Membrane Protein β-Barrel Domains in Clinical Strains Provides Insights into the Evolution of
Kumar S; Caimano MJ; Anand A; Dey A; Hawley KL; LeDoyt ME; La Vake CJ; Cruz AR; Ramirez LG; Paštěková L; Bezsonova I; Šmajs D; Salazar JC; Radolf JD
mBio; 2018 Jun; 9(3):. PubMed ID: 29895642
[TBL] [Abstract][Full Text] [Related]
13. The TprK protein of Treponema pallidum is periplasmic and is not a target of opsonic antibody or protective immunity.
Hazlett KR; Sellati TJ; Nguyen TT; Cox DL; Clawson ML; Caimano MJ; Radolf JD
J Exp Med; 2001 May; 193(9):1015-26. PubMed ID: 11342586
[TBL] [Abstract][Full Text] [Related]
14. Surface antigens of the syphilis spirochete and their potential as virulence determinants.
Blanco DR; Miller JN; Lovett MA
Emerg Infect Dis; 1997; 3(1):11-20. PubMed ID: 9126440
[TBL] [Abstract][Full Text] [Related]
15. Conservation of the 15-kilodalton lipoprotein among Treponema pallidum subspecies and strains and other pathogenic treponemes: genetic and antigenic analyses.
Centurion-Lara A; Arroll T; Castillo R; Shaffer JM; Castro C; Van Voorhis WC; Lukehart SA
Infect Immun; 1997 Apr; 65(4):1440-4. PubMed ID: 9119485
[TBL] [Abstract][Full Text] [Related]
16. Assessment of cell-surface exposure and vaccinogenic potentials of Treponema pallidum candidate outer membrane proteins.
Tomson FL; Conley PG; Norgard MV; Hagman KE
Microbes Infect; 2007 Sep; 9(11):1267-75. PubMed ID: 17890130
[TBL] [Abstract][Full Text] [Related]
17. Multiple alleles of Treponema pallidum repeat gene D in Treponema pallidum isolates.
Centurion-Lara A; Sun ES; Barrett LK; Castro C; Lukehart SA; Van Voorhis WC
J Bacteriol; 2000 Apr; 182(8):2332-5. PubMed ID: 10735882
[TBL] [Abstract][Full Text] [Related]
18. Surface immunolabeling and consensus computational framework to identify candidate rare outer membrane proteins of Treponema pallidum.
Cox DL; Luthra A; Dunham-Ems S; Desrosiers DC; Salazar JC; Caimano MJ; Radolf JD
Infect Immun; 2010 Dec; 78(12):5178-94. PubMed ID: 20876295
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Protective Ability of the Treponema pallidum subsp.
Haynes AM; Godornes C; Ke W; Giacani L
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31182617
[No Abstract] [Full Text] [Related]
20. Native surface association of a recombinant 38-kilodalton Treponema pallidum antigen isolated from the Escherichia coli outer membrane.
Fehniger TE; Radolf JD; Walfield AM; Cunningham TM; Miller JN; Lovett MA
Infect Immun; 1986 May; 52(2):586-93. PubMed ID: 3516880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
